

Review Article

The Cureus Journal of Medical Science is proud to introduce the publishing competition on Strategies to Promote Long-Term Cardiac Implant Site Health.
Cardiac implantable electronic devices (CIEDs) have become a vital standard of care for patients suffering from cardiac arrhythmias and heart failure. However, the tremendous benefits of CIEDs need to be balanced against the long-term risks and challenges of living with a medical device implant. Moreover, as patient survival increases, device reoperations become ever more common (e.g. device replacements or upgrades, or lead replacements or revisions).
Technical advances do not negate the human body’s response to soft tissue foreign implants, which by nature invokes inflammation, fibrosis, and encapsulation. Potential other sequela include hematoma, seroma, or infection at implant site; allergic reaction to device materials; device erosion or migration; dense fibrous encapsulation/calcification surrounding device and leads at implant site; changes in device heat dissipation, electrical sensing, or defibrillation thresholds; and implant site discomfort or poor cosmesis.
With the goal to document challenges, share clinical knowledge and experiences, and ultimately improve patient outcomes, we invite original submissions (case reports/series, original articles, technical reports and review articles) that contribute to deeper understanding of implant site difficulties and sharing of procedural strategies to promote long-term implant site health. Submissions should focus on one or more of the following topics:
To foster educational awareness, our goal is to share the results with the cardiology community worldwide. To encourage dissemination, all published materials will be Open Access and indexed with PubMed Central. We encourage any surgeon or clinician in the cardiology community to contribute!
Program administration has been enabled through the financial support of Aziyo. Article selection, editorial review, peer review, publication and competition winner determination are strictly independent of the sponsor.
All article submissions will undergo an independent pre-publication peer review conducted by a world-class team of experts.
The entry period is now closed. Competition entries appear below as they are published. Now is your chance to score and discuss these articles. Remember, honorariums will be awarded to the three highest-scoring articles!
Competition entry and article submission is entirely free. All submitted work must be previously unpublished. Eligible entries include original articles, case reports/series, review articles and technical reports.
All articles must be submitted and formatted via the template-driven, self-publishing Cureus platform. Authors are encouraged to include supporting images, charts, tables and/or videos within their article submissions. Reference limits vary by article type. For additional information on publishing with Cureus, please refer to our Author Guide.
Other Stipulations
Cureus publishing competitions are intended to encourage medical discovery and document clinical experiences – be they positive, negative, or neutral and foster broader educational outreach through Open Access publication that is free to both authors and readers.
Article submissions must adhere to the described “call for articles” and are open to any and all related manufacturer or vendor technologies.
As a firewall to ensure objective and credible science, article selection, editorial review, peer review and publication are strictly independent of the sponsoring company.
Winning articles are selected exclusively via peer review panel and community crowdsourced scoring. Neither the sponsoring company, nor Cureus, can determine the competition outcome.
Winning Article Awards
The three highest Cureus SIQ™ (Scholarly Impact Quotient™) scored published articles will be awarded an honorarium for Cureus Scientific Excellence™:
Subsequent to a formal editorial and peer review, published articles undergo SIQ scoring - Cureus’ unique crowdsourced, secondary peer-review process. In addition to measuring engagement, SIQ allows the community-at-large to rate the quality of individual articles. Reviewers assign scores from 1 to 10 on criteria including clarity and rationale, clinical importance, study design and methods, data analysis, novelty of conclusions and quality of presentation.
Aggregated community SIQ scores allow clinicians and researchers to quickly assess article quality in a manner similar to that of Amazon® and Yelp® community reviews.
Eligible articles must receive a minimum of five scores. (A Cureus user can assign only one score per article.) As engagement and scoring is critical to winning, authors are highly encouraged to share their published articles via social media and email.
Sunshine Act Reporting
Section 6002 of the Affordable Care Act requires applicable manufacturers of covered drugs, devices, biologicals, and medical supplies to report payments or other transfers of value made to physicians and teaching hospitals. For winning article and referral awards paid to “covered recipients,” award fees shall be supplied to Aziyo for subsequent Sunshine Act reporting.